AI Terminal
Amoéba
Capital/Financing Update • Jul 2, 2019
1107_rns_2019-07-02_85ef4c5e-77da-41eb-8018-472759d14710.pdf
Capital/Financing Update
Open in ViewerOpens in native device viewer
PRESS RELEASE
Chassieu, July 2,2019
Half-year review of the liquidity contract
Pursuant to the liquidity contract established by AMOEBA with PORTZAMPARC Trading Company, as of June 30, 2019, the liquidity account held the following assets:
- 19 476 AMOEBA shares,
- EUR 16,200.11
It is recalled that at the time of implementation, the following amount was held in the liquidity account:
▪ 200,000.00 euros.
About AMOEBA:
Amoéba's ambition is to become a major player in the treatment of bacterial risk in the fields of water, healthcare and plant protection. Our biological solution is an alternative to chemical products widely used today. Amoéba is currently focusing on the market of industrial cooling towers estimated at €1.7Bn (1) on a global chemical biocide market for water treatment, evaluated at €21Bn (2) and on the biocontrol market for plant protection estimated globally at €1.6Bn (4) . In the future, the Company is looking at developing new applications such as chronic wound care, estimated at € 751 million (3) in the USA. Sales of associated products with healthcare, biocides and crop protection are subject to the Company being granted local regulatory market authorizations. The Company is currently in a trial phase for biocidal and plant protection applications and does not market any products.
Created in 2010, based in Chassieu (Lyon, France) with a subsidiary in Canada and in the United States, Amoéba is quoted on the compartment C of Euronext Paris. The Company is a member of the BPIfrance Excellence network and is eligible for the PEA-PME SME equity savings plan setup. More information on www.amoebabiocide.com.
(1): Amoéba data combined from sources: DRIRE 2013, Eurostat, ARHIA 2013
(2): Sources combined by Amoéba from water treaters, Freedonia, Eurostat et MarketsandMarkets
(3): BCC Research, "Markets for Advanced Wound Management Technologies," Wellesley, MA, 2017
(4): Biopesticides Worldwide Market 2013, CPL, Wallingford, UK
Contacts: Amoéba Valérie FILIATRE General Manager +33 (0)4 26 69 16 00 [email protected]
Investors Relations Grégory BOSSON Agence Calyptus +33(0)1 53 65 37 90 [email protected]
Medias relations Constance LOZET Agence Ekno +33(0)7 78 41 19 70 [email protected]